TY  - JOUR
AU  - Compte, Marta
AU  - Harwood, Seandean Lykke
AU  - Muñoz, Ines G
AU  - Navarro, Rocio
AU  - Zonca, Manuela
AU  - Perez-Chacon, Gema
AU  - Erce-Llamazares, Ainhoa
AU  - Merino, Nekane
AU  - Tapia-Galisteo, Antonio
AU  - Cuesta, Angel M
AU  - Mikkelsen, Kasper
AU  - Caleiras, Eduardo
AU  - Nuñez-Prado, Natalia
AU  - Aznar, M Angela
AU  - Lykkemark, Simon
AU  - Martinez Torrecuadrada, Jorge Luis
AU  - Melero, Ignacio
AU  - Blanco, Francisco J
AU  - Bernardino de la Serna, Jorge
AU  - Zapata, Juan M
AU  - Sanz, Laura
AU  - Álvarez-Vallina, Luis
PY  - 2018
DO  - 10.1038/s41467-018-07195-w
SN  - 2041-1723
UR  - http://hdl.handle.net/20.500.12105/6702
AB  - The costimulation of immune cells using first-generation anti-4-1BB monoclonal antibodies (mAbs) has demonstrated anti-tumor activity in human trials. Further clinical development, however, is restricted by significant off-tumor toxicities associated...
LA  - eng
PB  - Nature Publishing Group
TI  - A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity
TY  - journal article
ER  -